Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production

American Journal of Nephrology

Volumn 30, Issue 3, 2009, Pages 232-243

  Melnyk, Roman A ^a   Tam, John ^a   Boie, Yves ^a   Kennedy, Brian P ^a   Percival, M David ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Angiotensin II; Prorenin; Renal diseases; Renin; Renin angiotensin system; Transforming growth factor

Indexed keywords

ANGIOTENSIN II; PRORENIN; RENIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIOINFORMATICS; CELL DAMAGE; CHILD; CONTROLLED STUDY; FEMALE; FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTROPHY; KIDNEY DISEASE; MALE; MESANGIUM CELL; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHOOL CHILD;

ANGIOTENSIN II; CELLS, CULTURED; CHILD; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MESANGIAL CELLS; MIDDLE AGED; RENIN; SIGNAL TRANSDUCTION;

EID: 65649138497     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000220260     Document Type: Article

References (34)

1. Griendling KK, Murphy TJ, Alexander RW: Molecular-biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.
2. Wolf G, Haberstroh U, Neilson EG: Angiotensin- II stimulates the proliferation and biosynthesis of type-i collagen in cultured murine mesangial cells. Am J Pathology 1992; 140: 95-107.
3. Kagami S, Okada K, Kuroda Y, Border WA, Noble NA: Effect of angiotensin-II on the expression of plasminogen-activator inhibitor (PAI)-1 in rat mesangial cells. J Am Soc Nephrol 1994; 5: 810.
4. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin-II stimulates extracellular-matrix protein-synthesis through induction of transforming growth-factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437.
5. Paul M, Mehr AP, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
6. Reid IA: Interactions between Ang-II, sympathetic nervous-system, and baroreceptor reflexes in regulation of blood-pressure. Am J Physiol 1992; 262:E763-E778.
7. Peach MJ: Renin-angiotensin system - biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313-370.
8. Eijkelkamp WBA, Zhang ZX, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D: Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 2007; 18: 1540-1546.
9. Peters H, Border WA, Noble NA: Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 1998; 54: 1570-1580.
10. Morgan T, Anderson A, Bertram D, MacInnis R: Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria. J Renin Angiotensin Aldosterone Syst 2004; 5: 64-71.
11. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD: Pivotal role of the renin/ prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109: 1417-1427.
12. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD: Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996; 50: 1897-1903.
13. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W: Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006; 69: 105-113.
14. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN, Nakagawa T, Nishiyama A, Suzuki F, Inagami T, Itoh H: Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 2007; 18: 1789-1795.
15. Huang Y, Noble NA, Zhang J, Xu C, Border WA: Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 2007; 72: 45-52.
16. Saris JJ, 't Hoen PA, Garrelds IM, Dekkers DH, den Dunnen JT, Lamers JM, Jan Danser AH: Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension 2006; 48: 564-571.
17. Sakoda M, Ichihara A, Kaneshiro Y, Takemitsu T, Nakazato Y, Nabi AH, Nakagawa T, Suzuki F, Inagami T, Itoh H: (Pro)renin receptor- mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res 2007; 30: 1139-1146.
18. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, Dechend R, Fiebeler A, Burckle C, Contrepas A, Jan Danser AH, Bader M, Nguyen G, Luft FC, Muller DN: Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 2008; 51: 682-688.
19. Schefe JH, Unger T, Funke-Kaiser H: PLZF and the (pro)renin receptor. J Mol Med 2008; 86: 623-627.
20. Paschalidou K, Neumann U, Gerhartz B, Tzougraki C: Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L -2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions. Biochem J 2004; 382: 1031-1038.
21. Heinrikson RL, Hui J, Zurcherneely H, Poorman RA: A structural model to explain the partial catalytic activity of human prorenin. Am J Hypertens 1989; 2: 367-380.
22. van Kesteren CAM, Danser AHJ, Derkx FHM, Lamers JMJ, Saxena PR, Schalekamp MADH: Mannose 6-phosphate receptormediated internalization and activation of prorenin by cultured neonatal rat cardiac myocytes and fibroblasts. Hypertension 1997; 30: 4.
23. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, Nishiyama A, Inagami T, Hayashi M: Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47: 894-900.
24. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, Ruiz P, Unger T, Funke-Kaiser H: A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 2006; 99: 1355-1366.
25. Zhang JD, Noble NA, Border WA, Owens RT, Huang YF: Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 2008; 295:E810-E819.
26. Kaneshiro Y, Ichihara A, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, Hayashi M, Inagami T: Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int 2006; 70: 641-646.
27. Freundlich M, Quiroz Y, Zhang ZY, Zhang Y, Bravo Y, Weisinger JR, Li YC, Rodriguez-Iturbe B: Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008; 74: 1394-1402.
28. Badellino KO, Wolfe ML, Reilly MP, Rader DJ: Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 2006; 3: 245-252.
29. Ishida T, Hirata K, Kojima Y, Tanaka H, Okada T, Quertermous T, Yokoyama M: Endothelial lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2005; 6(suppl):46-47.
30. Ishida T, Choi SSY, Kundu RK, Spin J, Yamashita T, Hirata K, Kojima Y, Yokoyama M, Cooper AD, Quertermous T: Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 2004; 279: 45085-45092.
31. Koster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li DS, Qiu YB, Fraser CC, Yang DD, Heuer JG, Jaskunas SR, Eacho P: Transgenic angiopoietin-like (angptl) 4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005; 146: 4943-4950.
32. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S: The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006; 281:933-944.
33. Atkins GB, Wang YM, Mahabeleshwar GH, Shi H, Gao HY, Kawanami DJ, Natesan V, Lin ZY, Simon DI, Jain MK: Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis. Circ Res 2008; 103: 690-693.
34. Kaschina E, Scholz H, Steckelings UM, Sommerfeld M, Kemnitz UR, Artuc M, Schmidt S, Unger T: Transition from atherosclerosis to aortic aneurysm in human coincides with an increased expression of RAS components. Atherosclerosis 2009, E-Pub ahead of print.